Charles River Laboratories, Inc. (NYSE: CRL), a leading global provider of solutions that advance the drug discovery and development process, and genOway, the European leader in genetically modified research models, announce the establishment of a three-year North American collaboration. This strategic alliance will provide pharmaceutical, biotechnology, and academic researchers with innovative research models to better understand human diseases.
